Masimo [MASI] vs Bio-Rad Laboratories [BIO] Detailed Stock Comparison

Masimo Corporation

NASDAQ
Loading...

Bio-Rad Laboratories Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Masimo Corporation wins in 7 metrics, Bio-Rad Laboratories Inc. wins in 13 metrics, with 0 ties. Bio-Rad Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Masimo Corporation Bio-Rad Laboratories Inc. Better
P/E Ratio (TTM) 46.47 10.98 Bio-Rad Laboratories Inc.
Price-to-Book Ratio 12.89 1.11 Bio-Rad Laboratories Inc.
Debt-to-Equity Ratio 77.55 18.58 Bio-Rad Laboratories Inc.
PEG Ratio 27.03 -0.05 Masimo Corporation
EV/EBITDA 28.15 18.75 Bio-Rad Laboratories Inc.
Profit Margin (TTM) -9.92% 29.42% Bio-Rad Laboratories Inc.
Operating Margin (TTM) 18.52% 8.87% Masimo Corporation
EBITDA Margin (TTM) 18.52% 8.87% Masimo Corporation
Return on Equity 23.43% 10.84% Masimo Corporation
Return on Assets (TTM) 8.86% 1.67% Masimo Corporation
Free Cash Flow (TTM) $193.10M $374.60M Bio-Rad Laboratories Inc.
1-Year Return 11.63% 26.01% Bio-Rad Laboratories Inc.
Price-to-Sales Ratio (TTM) 6.12 3.20 Bio-Rad Laboratories Inc.
Enterprise Value $9.72B $8.09B Masimo Corporation
EV/Revenue Ratio 6.37 3.13 Bio-Rad Laboratories Inc.
Gross Profit Margin (TTM) 59.95% 49.80% Masimo Corporation
Revenue per Share (TTM) $28 $95 Bio-Rad Laboratories Inc.
Earnings per Share (Diluted) $3.84 $27.85 Bio-Rad Laboratories Inc.
Beta (Stock Volatility) 1.20 1.16 Bio-Rad Laboratories Inc.
Short % of Float 6.81% 0.00% Bio-Rad Laboratories Inc.

Masimo Corporation vs Bio-Rad Laboratories Inc. Stock Performance Analysis

Loading Price Chart...

MASI
BIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Masimo Corporation0.00%0.63%0.78%2.54%30.08%41.25%
Bio-Rad Laboratories Inc.1.17%-0.70%16.87%10.73%-6.05%-5.24%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Masimo Corporation11.63%11.44%-25.04%256.34%498.24%798.85%
Bio-Rad Laboratories Inc.26.01%-24.07%-54.09%102.91%143.91%328.31%

Performance & Financial Health Analysis: Masimo Corporation vs Bio-Rad Laboratories Inc.

MetricMASIBIO
Market Information
Market Cap i$9.36B$7.60B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i558,463239,625
90 Day Avg. Volume i1,362,548284,785
Last Close$179.95$289.28
52 Week Range$125.94 - $179.99$222.80 - $343.12
% from 52W High-0.02%-15.69%
All-Time High$305.21 (Nov 15, 2021)$832.70 (Aug 30, 2021)
% from All-Time High-41.04%-65.26%
Growth Metrics
Quarterly Revenue Growth0.12%0.04%
Quarterly Earnings GrowthN/A0.04%
Financial Health
Profit Margin (TTM) i-0.10%0.29%
Operating Margin (TTM) i0.19%0.09%
Return on Equity (TTM) i0.23%0.11%
Debt to Equity (MRQ) i77.5518.58
Cash & Liquidity
Book Value per Share (MRQ)$13.84$276.16
Cash per Share (MRQ)$2.92$57.08
Operating Cash Flow (TTM) i$217.80M$532.20M
Levered Free Cash Flow (TTM) i$316.41M$256.55M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Masimo Corporation vs Bio-Rad Laboratories Inc.

MetricMASI (Apr 24, 2026)BIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i46.4710.98
Forward P/E i27.0326.94
PEG Ratio i27.03-0.05
Price to Sales (TTM) i6.123.20
Price to Book (MRQ) i12.891.11
Market Capitalization
Market Capitalization i$9.36B$7.60B
Enterprise Value i$9.72B$8.09B
Enterprise Value Metrics
Enterprise to Revenue i6.373.13
Enterprise to EBITDA i28.1518.75
Risk & Other Metrics
Beta i1.201.16
Book Value per Share (MRQ) i$13.84$276.16

Financial Statements Comparison: Masimo Corporation vs Bio-Rad Laboratories Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMASI (2025)BIO (2025)
Revenue/Sales i1.53B2.58B
Cost of Goods Sold i581.70M1.24B
COGS % of Revenue i38.1%48.1%
Gross Profit i945.20M1.34B
Gross Margin i61.9%51.9%
Research & Development i126.40M275.60M
Operating Income (EBIT) i312.80M218.60M
Operating Margin i20.5%8.5%
EBITDA i355.00M480.70M
EBITDA Margin i23.2%18.6%
Pre-Tax Income i272.60M995.50M
Pre-Tax Income % of Revenue i17.9%38.5%
Income Tax i64.90M235.60M
Income Tax % of Revenue i4.3%9.1%
Net Income (Profit) i-151.50M759.90M
Profit Margin i-9.9%29.4%

Balance Sheet & Liquidity Metrics

MetricMASI (2025)BIO (2025)
Cash & Equivalents i152.30M529.80M
Total Current Assets i926.00M2.91B
Total Current Assets % of Revenue i60.6%112.5%
Total Current Liabilities i371.60M517.00M
Total Current Liabilities % of Revenue i24.3%20.0%
Long-Term Debt i544.90M1.35B
Long-Term Debt % of Revenue i35.7%52.2%
Total Shareholders Equity i721.20M7.45B
Retained Earnings i1.34B8.18B
Retained Earnings % of Revenue i87.7%316.5%
Property, Plant & Equipment i237.20M1.49B

Cash Flow Statement Comparison

MetricMASI (2025)BIO (2025)
Operating Cash Flow i198.40M1.25B
Operating Cash Flow % of Revenue i13.0%48.4%
Capital Expenditures i200,000-157.50M
Free Cash Flow i193.10M374.60M
FCF Margin i12.6%14.5%
Debt Repayment i-1.28B-500,000
Common Stock Repurchase i-363.70M-295.50M

Short Interest & Institutional Ownership Analysis

MetricMASIBIO
Shares Short i3.25M26
Short Ratio i1.680.00
Short % of Float i6.81%0.00%
Shares Outstanding i52.10M26.99M
Float Shares i47.45M21.13M
% Held by Insiders i5.00%16.20%
% Held by Institutions i109.04%91.50%
% Held by Public i-14.04%-7.70%

Dividend Analysis & Yield Comparison: Masimo Corporation vs Bio-Rad Laboratories Inc.

MetricMASIBIO
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A